Cargando…
Ruxolitinib therapy and telomere length in myelofibrosis
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098263/ https://www.ncbi.nlm.nih.gov/pubmed/27716743 http://dx.doi.org/10.1038/bcj.2016.91 |
| _version_ | 1782465752411930624 |
|---|---|
| author | Caocci, G Greco, M Delogu, G Secchi, C Perra, A Ghiani, S Orru, F Vacca, A Galimi, F La Nasa, G |
| author_facet | Caocci, G Greco, M Delogu, G Secchi, C Perra, A Ghiani, S Orru, F Vacca, A Galimi, F La Nasa, G |
| author_sort | Caocci, G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5098263 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50982632016-11-18 Ruxolitinib therapy and telomere length in myelofibrosis Caocci, G Greco, M Delogu, G Secchi, C Perra, A Ghiani, S Orru, F Vacca, A Galimi, F La Nasa, G Blood Cancer J Letter to the Editor Nature Publishing Group 2016-10 2016-10-07 /pmc/articles/PMC5098263/ /pubmed/27716743 http://dx.doi.org/10.1038/bcj.2016.91 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Caocci, G Greco, M Delogu, G Secchi, C Perra, A Ghiani, S Orru, F Vacca, A Galimi, F La Nasa, G Ruxolitinib therapy and telomere length in myelofibrosis |
| title | Ruxolitinib therapy and telomere length in myelofibrosis |
| title_full | Ruxolitinib therapy and telomere length in myelofibrosis |
| title_fullStr | Ruxolitinib therapy and telomere length in myelofibrosis |
| title_full_unstemmed | Ruxolitinib therapy and telomere length in myelofibrosis |
| title_short | Ruxolitinib therapy and telomere length in myelofibrosis |
| title_sort | ruxolitinib therapy and telomere length in myelofibrosis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098263/ https://www.ncbi.nlm.nih.gov/pubmed/27716743 http://dx.doi.org/10.1038/bcj.2016.91 |
| work_keys_str_mv | AT caoccig ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT grecom ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT delogug ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT secchic ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT perraa ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT ghianis ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT orruf ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT vaccaa ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT galimif ruxolitinibtherapyandtelomerelengthinmyelofibrosis AT lanasag ruxolitinibtherapyandtelomerelengthinmyelofibrosis |